What are the optimal first-line therapies for patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer?
Annals of Palliative Medicine · 2023
DOI: 10.21037/apm-22-1391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Palliative Medicine, 2023. Verfasst von Koichi Taira und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Colonic Neoplasms.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Zitieren
APA
Taira, K., Kimura, A., Nakata, A., Tanaka, F., Nagami, Y., & Fujiwara, Y. (2023). What are the optimal first-line therapies for patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer?. Annals of Palliative Medicine. https://doi.org/10.21037/apm-22-1391
Vancouver
Taira K, Kimura A, Nakata A, Tanaka F, Nagami Y, Fujiwara Y. What are the optimal first-line therapies for patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer?. Annals of Palliative Medicine. 2023. doi:10.21037/apm-22-1391
BibTeX
@article{Taira2023,
author = {Taira, Koichi and Kimura, Akie and Nakata, Akinobu and Tanaka, Fumio and Nagami, Yasuaki and Fujiwara, Yasuhiro},
title = {What are the optimal first-line therapies for patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer?},
journal = {Annals of Palliative Medicine},
year = {2023},
doi = {10.21037/apm-22-1391}
}
EUVIMED